Figure 6.
Figure 6. Development and diversification of IgM+IgD+CD27+ peripheral B cells from healthy and asplenic children. (A) (B) (C) (D) Percentage of IgM+IgD+CD27+ peripheral B cells from healthy (A) and asplenic children (C) younger than 5 years. Mutation frequency of rearranged V3-23 genes from IgM+IgD+CD27+ peripheral B cells of healthy (B) and asplenic children (D). In panels B and D, each bar represents the mutation frequency of one individual, and the values marked above the bars represent the mutation range over the 288 bp V3-23 sequence analyzed; healthy adult values are pooled from 5 individuals. (E) IgD/CD27 staining profiles of peripheral CD19+ lymphocytes of asplenic individuals from 14 months to 71 years. The percentage of cells in each CD27+ quadrant is indicated. A complete description of asplenic patients is given in Table 3.

Development and diversification of IgM+IgD+CD27+ peripheral B cells from healthy and asplenic children. (A) (B) (C) (D) Percentage of IgM+IgD+CD27+ peripheral B cells from healthy (A) and asplenic children (C) younger than 5 years. Mutation frequency of rearranged V3-23 genes from IgM+IgD+CD27+ peripheral B cells of healthy (B) and asplenic children (D). In panels B and D, each bar represents the mutation frequency of one individual, and the values marked above the bars represent the mutation range over the 288 bp V3-23 sequence analyzed; healthy adult values are pooled from 5 individuals. (E) IgD/CD27 staining profiles of peripheral CD19+ lymphocytes of asplenic individuals from 14 months to 71 years. The percentage of cells in each CD27+ quadrant is indicated. A complete description of asplenic patients is given in Table 3.

Close Modal

or Create an Account

Close Modal
Close Modal